Related Experiment Video
Updated: Feb 12, 2026

An Improved Protocol to Purify and Directly Mono-Biotinylate Recombinant BDNF in a Tube for Cellular Trafficking Studies in Neurons
Published on: July 11, 2020
Long noncoding RNA BDNF-AS is downregulated in cervical cancer and has anti-cancer functions by negatively
Huimin Zhang1, Caihong Liu1, Ting Yan1
1Department of Gynaecology, Guizhou Provincal People's Hospital, Guiyang, Guizhou Province, 550002, China.
Purpose:
We investigated expression and mechanism long noncoding RNA BDNF-AS in human cervical cancer (CC).
Methods:
BDNF-AS expressions were examined by qPCR in CC cell lines and human CC tumors. CC cell lines, SiHa and DoTc2-4510 were transduced with lentivirus to ectopically overexpress BDNF-AS. Possible anti-cancer effects of BDNF overexpression were examined on CC in vitro proliferation and migration, and in vivo transplantation. Human BDNF gene expression was also examined in CC cell lines and tumors. In CC cells with overexpressed BDNF-AS, BDNF was upregulated to examine its direct effect in NDNF-AS-modulated CC proliferation and migration.
Results:
BDNF was downregulated in both CC cells and human CC tumors. In CC cells, BDNF-AS overexpression is anti-cancer by inhibiting proliferation and migration in vitro, and transplantation in vivo. BDNF was inversely expressed as BDNF-AS in CC. Upregulation of BDNF in BDNF-AS-overexpressed CC cells reversed the anti-cancer effects of BDNF-AS.
Conclusion:
BDNF-AS is downregulated in CC. Overexpressing BDNF-AS may inhibit CC, possibly through inverse regulation on BDNF.
Insights
Long noncoding RNA BDNF-AS is downregulated in cervical cancer (CC). Overexpressing BDNF-AS inhibits CC cell proliferation and migration, potentially via inverse regulation of BDNF.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cervical cancer (CC) remains a significant global health challenge.
- Understanding the molecular mechanisms underlying CC progression is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To investigate the expression and functional role of the long noncoding RNA (lncRNA) BDNF-AS in human cervical cancer.
- To elucidate the mechanism by which BDNF-AS influences CC progression, particularly its relationship with BDNF.
Main Methods:
- Quantitative real-time PCR (qPCR) was used to assess BDNF-AS and BDNF expression in CC cell lines and tumor tissues.
- Lentiviral vectors were employed to overexpress BDNF-AS in CC cells (SiHa and DoTc2-4510).
- In vitro assays evaluated the effects of BDNF-AS overexpression on CC cell proliferation and migration, while in vivo studies assessed tumor transplantation.
Main Results:
- BDNF expression was found to be downregulated in both CC cell lines and human CC tumors.
- Overexpression of BDNF-AS demonstrated anti-cancer effects by inhibiting CC cell proliferation and migration in vitro, and reducing tumor growth in vivo.
- BDNF-AS and BDNF exhibited inverse expression patterns in CC.
- Restoring BDNF levels in BDNF-AS-overexpressing cells reversed the observed anti-cancer effects.
Conclusions:
- BDNF-AS is significantly downregulated in cervical cancer.
- Ectopic expression of BDNF-AS exhibits potent anti-cancer properties in CC, likely through the inverse regulation of BDNF.
- Targeting BDNF-AS may represent a promising therapeutic avenue for cervical cancer treatment.
Related Concept Videos
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

